CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

BRAF non-V600 — resistance to vemurafenib

Gene: BRAF · Type: mutation

Indications: Melanoma

FDA Sensitivity Assertions

No sensitivity assertions.